The article reports that a woman died after taking a combination of ketamine and MDMA during a so-called “clarity” ceremony for which she had paid a doctor $2,000. It matters because it raises concerns about the safety, supervision and regulation of privately run drug-assisted wellness or therapeutic-style sessions, particularly when powerful psychoactive substances are involved.

From the text provided, the central facts are that the event was presented as a “clarity” ceremony, the woman reportedly paid $2,000, and the substances involved were ketamine and MDMA. The excerpt does not include fuller details such as where the ceremony took place, exactly what happened medically, or whether any criminal or professional proceedings followed, but the case is framed as a tragedy linked to the mixing of those drugs under a doctor’s supervision.